- Author:
Oh Chan KWON
1
;
Soohyun KIM
;
Seokchan HONG
;
Chang Keun LEE
;
Bin YOO
;
Eun Ju CHANG
;
Yong Gil KIM
Author Information
- Publication Type:Review
- Keywords: IL-32; Rheumatoid arthritis; Ankylosing spondylitis; Inflammation; Osteoclasts; Osteoblasts
- MeSH: Arthritis*; Arthritis, Rheumatoid; Autoimmune Diseases; Bone Resorption; Inflammation; Metabolism*; Monocytes; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Spondylitis, Ankylosing
- From:Immune Network 2018;18(3):e20-
- CountryRepublic of Korea
- Language:English
- Abstract: IL-32 acts as a pro-inflammatory cytokine by inducing the synthesis of inflammatory molecules as well as promoting the morphological changes involved in the transformation of monocytes into osteoclasts (OCs). Evaluation of the functions of IL-32 has mainly focused on its inflammatory properties, such as involvement in the pathogenesis of various autoimmune diseases. Recently, IL-32 was shown to be involved in bone metabolism, in which it promotes the differentiation and activation of OCs and plays a key role in bone resorption in inflammatory conditions. IL-32γ also regulates bone formation in conditions such as ankylosing spondylitis and osteoporosis. In this review, we summarize the results of recent studies on the role of IL-32γ in bone metabolism in inflammatory arthritis.